Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 8-K call announcement, 10-Q stay in one workspace.
KYTX
$5.84
-3.31%
KYTX
· Kyverna Therapeutics, Inc.
$5.84
-0.20 (-3.31%)
At close · Oct 21
Return incl. dividend (before tax)
Market Cap
$373.53M
Shares
61.84M
Volume · Oct 21
829.53K
Avg daily vol (3M)
832.78K
All webcasts
Earnings call · FY2026 Q1
Kyverna Therapeutics, Inc. (KYTX) Q1 2026 Earnings Call
Diluted EPS
-$0.66
Net income
-$39.73M
Research coverage
3 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed May 12, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed May 12, 2026 · complete as-filed document
SEC call announcement
8-K call announcement
Filed Apr 22, 2026 · complete as-filed document